Publications on EmboGold Microspheres and Embosphere Microspheres for treatment of Uterine Fibroids and Meningioma

Company Publications

Company Literature
	EmboGold Updated Brochure

	Embosphere Updated Brochure

	Patient Guide for Embolization

	EmboGold Microspheres Preparation & Administration

Press Releases
	BioSphere Medical to Be Acquired by Merit Medical Systems for Approximately $96 Million in Cash

	Study Finds That Gyns Who Refer Patients to IRs for UFE Evaluation Receive Back an Average of 19% More Patients Than They Refer

	BioSphere Medical to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference

	BioSphere Medical Announces Retirement of William M. Cousins, Jr

	BioSphere Medical Schedules Fourth Quarter 2009 Financial Results Conference Call February 11

	BioSphere Medical to Present at the 12th Annual Needham Growth Stock Conference

	BSMD Submits IDE to FDA for QuadraSphere(R) for Use with Doxorubicin for the Treatment of Primary Liver Cancer

	BioSphere Medical Schedules Third Quarter 2009 Financial Results Conference Call October 29

	Study Shows Uterine Artery Embolization Compares Favorably to Laparoscopic Bilateral Occlusion for Treating Uterine Fibroids

	BioSphere Medical's HepaSphere Highlighted at Two Scientific Meetings in Europe

	BioSphere Medical to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

	BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization

	BioSphere Medical Schedules Second Quarter 2009 Financial Results Conference Call July 30

	BioSphere Medical to Present at the Noble Financial Equity Conference

	BioSphere Medical Announces First Quarter Results; 15% Growth in U.S. Embolics and Delivery System Revenue

	BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market

	BioSphere Medical Schedules First Quarter 2009 Financial Results Conference Call April 30

	Webcast Alert: Lippert/Heilshorn Life Sciences Conference Presentation (BioSphere Medical Inc.)

	BioSphere Medical Fourth Quarter Results Feature 24% Growth in U.S. Revenue for Embolics and Delivery Systems

	BioSphere Medical Schedules Fourth Quarter 2008 Financial Results Conference Call February 12

	BioSphere's UFE Awareness Campaign Continues with NBC-TV "Today" Show Appearance by Beverly Johnson

	BioSphere Medical to Present at Two Upcoming Conferences

	BioSphere to Hold Symposium on Physician Collaboration in Fibroid Treatments at AAGL

	BioSphere Revs Up UFE Marketing Campaign with Beverly Johnson Appearance on Good Day Atlanta

	n easier way to shrink fibroids - PARADE

	CIRSE Congress News: Bridging the Gap Between Interventional Radiology and Its Potential Patients

	BioSphere Medical to Present at the Wall Street Analyst Forum Conference

	BioSphere Medical Announces ACOG Practice Bulletin Recommendation of Uterine Artery Embolization as Alternative to Hysterectomy

	BioSphere Medical to Present at the Noble Financial Equity Conference

	BioSphere Medical to Present at Canaccord Adams Global Growth Conference

	BioSphere Medical to Present at BMO Capital Markets Focus on Healthcare Conference

	BioSphere Medical Reports 2008 Second Quarter Financial Results

	BioSphere Medical Schedules Second Quarter 2008 Financial Results Release and Conference Call

	BioSphere Medical to Present at CapStone Investments' 2nd Annual Small-Cap Investor Conference

	BioSphere Medical Highlights the Health and Practice Economic Benefits of Patient Loyalty

	BioSphere Medical Schedules First Quarter 2008 Financial Results Release and Conference Call

	BioSphere Medical Supports ACOG Committee Opinion on Surgery and Patient Choice

	BioSphere Medical Highlights Patient and Economic Benefits When Ob/Gyns and Interventional Radiologists Collaborate

	BioSphere Medical to Present at B. Riley's 9th Annual Las Vegas Investor Conference

	BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China

	BioSphere Medical Highlights Scheduled Presentations and Abstracts at the 2008 SIR 33rd Annual Scientific Meeting

	BioSphere Medical Announces Appointment of Dr. Linda D. Bradley to Medical Advisory Board

	BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development

	BioSphere Medical to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference

	BioSphere Medical Reports 2007 Fourth Quarter and Year-End Financial Results

	BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China

	BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales

	Study Published in JVIR Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization

	BioSphere Medical Names Melodie R. Domurad, Ph.D., Vice President of Regulatory, Medical Affairs, and Quality Systems

	BioSphere Medical to Present at Needham & Company LLC 10th Annual Growth Stock Conference

	Three-Year Data Published in Obstetrics & Gynecology Demonstrates Long-Term Efficacy and Durability of Uterine Fibroid Embolization (UFE)

	Three-Year Registry Data from 1,278 Women Shows Long-

	BioSphere Medical Announces 113% Increase in CMS Hospital Outpatient Reimbursement Rate for Uterine Fibroid Embolization

	BioSphere Medical to Present at Stephens Inc. Fall Investment Conference

	BioSphere Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

	BioSphere Medical to Present at Roth 2007 New York Conference

	BioSphere Medical to Present at CIRSE 2007 Conference

	BioSphere Medical Schedules Second Quarter 2007 Financial Results Release and Conference Call

	BioSphere Medical to Present at C.E. Unterberg, Towbin Emerging Growth Conference

	BioSphere Medical Reports First Quarter 2007 Financial Results

	BioSphere Medical Schedules First Quarter 2007 Financial Results Release and Conference Call

	Article Published in the Journal of Vascular and Interventional Radiology Supports Long-Term Efficacy and Durability of Embosphere Microspheres

	BioSphere Medical Highlights a Scheduled Presentation and Abstracts at the 2007 SIR 32nd Annual Scientific Meeting

	BioSphere Medical to Present at Roth Capital Partners 19th Annual OC Conference

	BioSphere Medical Reports Fourth Quarter 2006 Financial Results

	New England Journal of Medicine Study Finds UFE Provides Same QOL Benefit as Surgery

	BioSphere Medical Announces That a Live-Case and Scientific Presentation Featuring BioSphere's QuadraSphere Microspheres

	BioSphere Medical Schedules Fourth Quarter and Year End 2006 Financial Results Release and Conference Call

	BioSphere Medical Provides Update on Physician UFE Reimbursement Based on the Centers for Medicare and Medicaid Services (CMS) Preliminary Rule

	BioSphere Medical Receives FDA Approval For QuadraSphere(TM) Microspheres

	Research Reveals More Women with Fibroids Discussing Uterine Fibroid Embolization (UFE) with Their Physicians

	BioSphere Medical Reports Third Quarter 2006 Financial Results

	BioSphere Medical to Present at Rodman & Renshaw's 8th Annual Healthcare Conference

	BioSphere Medical to Present at C.E. Unterberg, Towbin Life Sciences Conference

	BioSphere Medical Schedules Third Quarter 2006 Financial Results Release and Conference Call

	BioSphere Medical to Present at A.G. Edwards' Emerging Growth Conference 2006

	BioSphere Medical to Present at Roth Capital Partners 2006 New York Conference

	BioSphere Medical's HepaSphere(TM) Microspheres to Be Featured at CIRSE 2006 Conference

	FDA Clears BioSphere Medical's Next Generation EmboCath(R) Plus Infusion Microcatheter

	BioSphere Medical Reports Second Quarter 2006 Financial Results

	BioSphere Medical to Announce 2nd Quarter 2006 Earnings Results

	Arterial Embolization Effective in Patients with Liver Cancer Recurrence

	BioSphere Medical to Participate in Phase II Liver Cancer Study at The Johns Hopkins University School of Medicine

	FDA Clears BioSphere Medical's Next Generation Sequitor(TM) Steerable Guidewire

	Marian L. Heard Elected to BioSphere Medical's Board of Directors

	BioSphere Medical to Present at Rodman and Renshaw 3rd Annual Global Healthcare Conference

	BioSphere Medical Reports First Quarter 2006 Financial Results; Revenues Increase 19% to a Record $5.3 Million

	BioSphere Medical To Announce 1st Quarter 2006 Earnings Results

	BioSphere Announces Three Year Data

	BioSphere Medical Announces Three-Year Study

	BioSphere Medical Voluntarily Recalls HepaSphere™ Microspheres to Correct Package Defect

	12 Month Data Presented at SIR
	12 moth data presented at SIR

Media
	Less drastic treatment for uterine fibroids a safe alternative to surgery, study says

	BioSphere Medical Announces Agreement for $13.4 Million Private Placement

	BioSphere Medical Reports Fourth Quarter and Full Year 2005 Financial Results

	Wall Street Journal Article